← Back to Clinical Trials
Recruiting NCT02976480

NCT02976480 The Irrigation or No Irrigation in Simple Lacerations Trials

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02976480
Status Recruiting
Phase
Sponsor Université de Sherbrooke
Condition Laceration - Injury
Study Type INTERVENTIONAL
Enrollment 1,000 participants
Start Date 2017-01
Primary Completion 2025-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
IrrigationNo irrigation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,000 participants in total. It began in 2017-01 with a primary completion date of 2025-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to determine whether the irrigation or non-irrigation of a simple laceration treated in the emergency department has an effect on the subsequent rate of infection.

Eligibility Criteria

Inclusion Criteria: * age 18 or older * repair within 18 hours from time of injury * repair done by the emergency room physician or trainee * clean and simple lacerations (clean edge with no gross contamination, as assessed by the treating physician) Exclusion Criteria: * pregnant patients * involving tendons, muscles, fascias, articulations * located on the ear, nose or distal to metacarpophalangeal or metatarsophalangeal joint * immunosuppressed (neutropenia, chronic corticotherapy, HIV, immunosuppressive therapy within 3 months) * bite wounds * lacerations with any loss of substance * lacerations with foreign body * complex lacerations (crush, stellate) * grossly contaminated

Contact & Investigator

Central Contact

Julien Bouchard, MD, CCFP(EM)

✉ julien.bouchard@usherbrooke.ca

📞 418-541-1000

Principal Investigator

Julien Bouchard, MD, CCFP(EM)

PRINCIPAL INVESTIGATOR

Université de Sherbrooke

Frequently Asked Questions

Who can join the NCT02976480 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Laceration - Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02976480 currently recruiting?

Yes, NCT02976480 is actively recruiting participants. Contact the research team at julien.bouchard@usherbrooke.ca for enrollment information.

Where is the NCT02976480 trial being conducted?

This trial is being conducted at Chicoutimi, Canada.

Who is sponsoring the NCT02976480 clinical trial?

NCT02976480 is sponsored by Université de Sherbrooke. The principal investigator is Julien Bouchard, MD, CCFP(EM) at Université de Sherbrooke. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology